LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Provided By GlobeNewswire
Last update: Mar 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute
is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers
NASDAQ:LIXTW (8/1/2025, 8:00:02 PM)
0.2499
+0.02 (+8.65%)
4.87
+0.9 (+22.67%)
Find more stocks in the Stock Screener
